Grit Biotechnology
Clinical trials sponsored by Grit Biotechnology, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Immune cells from your own tumor could fight cervical cancer Results expected Jan 2027 (estimated)
- Immune cells from your tumor could fight cancer again Results expected Apr 2027 (estimated)
- Patient's own immune cells take on head and neck cancer in new trial Results expected Apr 2027 (estimated)
- Immune cells harvested from tumors could fight advanced colorectal cancer Results expected May 2027 (estimated)
- Immune cells from your own tumor could fight cancer Results expected Jun 2027 (estimated)
-
Immune cells take on tough tumors in early trial
Disease control OngoingThis early-stage trial tests a personalized cell therapy (TIL injection) for people with advanced solid tumors that have spread or come back. The treatment uses the patient's own immune cells, grown in a lab, to fight the cancer. The main goal is to check safety, and the study wi…
Phase 1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Experimental cell therapy aims to fight advanced cancers
Disease control CancelledThis study was designed to test a new treatment called GT307 for people with advanced solid tumors that have spread or come back after standard therapy. GT307 uses a patient's own immune cells (tumor-infiltrating lymphocytes) to attack the cancer. The main goals were to check saf…
Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Experimental cell therapy for advanced gynecological cancers halted before start
Disease control CancelledThis study aimed to test an experimental treatment called GT316, made from a patient's own immune cells (tumor-infiltrating lymphocytes), for advanced gynecological cancers. The goal was to check the safety and side effects of this cell therapy. However, the study was withdrawn b…
Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC